Navigation Links
Speid & Associates Partners With Genizon BioSciences to Reduce Attrition Rates of New Drug Compounds
Date:2/25/2009

SAN DIEGO and MONTREAL, Feb. 25 /PRNewswire/ -- Speid & Associates, an international regulatory and drug development consultancy firm today announced that it has entered into a partnership with Genizon BioSciences to increase success rates of new drug compounds using Genizon's proprietary genetic platform. In this challenging economic climate in which innovative pharmaceutical and biotechnology companies have to watch every dollar that is spent on drug development, the Genizon and Speid collaboration will help to increase the ultimate success of drug development programs. Genizon's predictive techniques will also enable Speid's clients to identify and eliminate compounds with relatively low chances of success earlier than if these techniques are not used.

"As we develop effective regulatory strategies for our clients' drug candidates, I am very pleased that Genizon will work alongside us at our clients' requests," said Lorna Speid, Ph.D., president of Speid & Associates. Dr. Speid added, "I anticipate that the Genizon technology and expertise will allow our clients to re-visit compounds that may have been placed on the 'back-burner', but which may hold promise as new medications."

"We believe that we can add significant value to Speid & Associates' clients through pharmacogenomic studies and analyses using our gene discovery platform and expertise. These enable invaluable insights into drug response, and therefore improve clinical trial outcomes," said Majid Belouchi, Ph.D., founder and chief scientific officer of Genizon. He added, "We use predictive biomarkers to identify patients who are more likely to respond to a given treatment. Consequently, the combination of Genizon's proprietary gene discovery platform and Speid's expertise in regulatory affairs will assure expeditious pathways to commercialization."

About Genizon BioSciences

Genizon BioSciences Inc. is a lead
'/>"/>

SOURCE Genizon BioSciences Inc.; Speid & Associates, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. NSF International Acquires David Begg Associates
2. Micromet to Present at the Sachs Associates 7th Annual Biotech in Europe Investor Forum
3. QED International Associates Announces Changes to the HealthShares(TM) Autoimmune-Inflammation and Neuroscience Indexes
4. QED International Associates Announces Changes to the HealthShares(TM) Autoimmune-Inflammation and Neuroscience Indexes - Correction
5. QED International Associates Announces Changes to the HealthShares(TM) Composite, HealthShares(TM) Cancer and HealthShares(TM) Neuroscience Indexes
6. QED International Associates Announces Changes to the HealthShares(TM) Composite and HealthShares(TM) Respiratory/Pulmonary Indexes
7. Halogen Receives High Ratings from Bersin & Associates - Company recognized as a market leader, and receives praise for outstanding customer satisfaction
8. QED International Associates Announces Changes to the HealthShares(TM) Dermatology and Wound Care Index
9. Lambert, Edwards & Associates Named Agency of Record for The West Michigan Science & Technology Initiative
10. QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes (As Revised)
11. Abt Associates Clinical Trials Announces Name Change to Abt Bio-Pharma Solutions, Inc.

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...poricidin disinfectant solution and wipes are reli...ainst H1N1 and Influenza A., , ... Contec Inc, the leading manufacturer of clean ro... disinfectants have been deemed by the EPA as eff...Pandemic 2009 H1N1 influenza A virus (the swine fl...
(Date:11/23/2009)...re/--PearlTherapeuticsInc.,abiopharmaceuticalcompa...ronicrespiratorydiseases,todayannouncedtheappointm...osenhas25yearsofexperienceinthepharmaceuticalandbi...encesandALZACorporation.Hisappointmentincreasesthe...bringsawealthofproductdevelopment,commercializatio...
(Date:11/20/2009)... -- Veridiam (www.veridiam.com) won the prestigiou...t the 2009 Workplace Excellence Awards. The awards...Resources Management and recognize innovative and ...iam was one of nine winners, selected from more th...e recent awards ceremony. San Diego-based Veridiam...
(Date:11/20/2009)...e-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nas...Circuit Court of Appeals reversed a U.S. District ...o pursue all of its claims against The Lash Group,...rial. CTI filed a complaint against The Lash Grou...nt for CTI,s product TRISENOX, in 2007 seeking $22...
Breaking Biology Technology:Sporicidin Brand Disinfectant Kills H1N1 in 3 Minutes 2Pearl Therapeutics Appoints Howie Rosen to Board of Directors 2Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category 2Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2
...J., Jan. 31 Schering-Plough,Corporation (NYSE: S...dministration (FDA) has accepted the Peg-IFN (pegi...Application (sBLA) for review and has,granted Prio...atients with,Stage III melanoma. Schering-Plough s... of 2007., The Priority Review designation is int...
...l School Researchers Used Thermo Scientific Dharma...for Reproduction of the Virus that ...1 Thermo Fisher,Scientific Inc., the world leader...interference (RNAi) technology has enabled a groun...n, which identified human proteins,required for gr...
...Manufacture ARIUS, Product Candidate Trop-2 Signal...PRINCETON, N.J., Jan. 31 Laureate Pharma, Inc., a...rotein production company, today,announced that it...reement,with ARIUS Research, Inc., a biotechnology... next wave of antibody therapeutics to treat cance...
Other Biology Technology:FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma 2FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma 3FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma 4FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma 5FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma 6Research Using Thermo Fisher Scientific RNA-Interference Technology Unveils Potential New Targets for HIV Drugs 2Research Using Thermo Fisher Scientific RNA-Interference Technology Unveils Potential New Targets for HIV Drugs 3Research Using Thermo Fisher Scientific RNA-Interference Technology Unveils Potential New Targets for HIV Drugs 4Research Using Thermo Fisher Scientific RNA-Interference Technology Unveils Potential New Targets for HIV Drugs 5Laureate Announces Manufacturing Agreement with ARIUS for Trop-2 Targeting Antibody 2Laureate Announces Manufacturing Agreement with ARIUS for Trop-2 Targeting Antibody 3
(Date:11/23/2009)... , This release is available in German . ,...instrument wouldn,t be a bad thing. It could help ...ble to measure. However, it must do so constructiv...ical measurement with more than just imagination, ...ysics have formulated a theory of spatial percepti...
(Date:11/23/2009)... , This release is available in German . ,...ace a long journey every year. Researchers at Prin... Institute for Ornithology in Radolfzell, Germany ...ant family of bats, the so-called "Vespertilionida...overed that the migration over short as well as lo...
(Date:11/22/2009)... , CINCINNATI -- Children exposed prenatally to t...articularly high risk for ADHD, according to resea... Center. , The study estimates that up to 35 per... 8 and 15 could be reduced by eliminating both of ...e into up to 800,000 children , "Tobacco and le...
Breaking Biology News(10 mins):Visual assistance for cosmic blind spots 2Visual assistance for cosmic blind spots 3Visual assistance for cosmic blind spots 4We're off then: The evolution of bat migration 2Exposure to lead, tobacco smoke raises risk of ADHD 2UC Riverside research on barley genome gets boost from 241 million USDA grant 9853 1UC Riverside research on barley genome gets boost from 241 million USDA grant 9853 2UC Riverside research on barley genome gets boost from 241 million USDA grant 9853 3UC Riverside research on barley genome gets boost from 241 million USDA grant 9853 4Hanson Technologies Inc Awarded Patent for its Advanced Food Pathogen Detection System 13956 1Hanson Technologies Inc Awarded Patent for its Advanced Food Pathogen Detection System 13956 2MRSA May Succumb to Honey 56675 1MRSA May Succumb to Honey 56675 2
...sociation of Biology Teachers (NABT) will recogniz...niversity of Minnesota, with the 2008 Evolution Ed... be held 15-18 October 2008 in Memphis, Tennessee.... by the American Institute of Biological Sciences ...y (BSCS). The award is presented in recognition o...
...ted as to the exact cell type that produces connec... the wound healing process. This knowledge gap is ...Fibrogenesis & Tissue Repair , a new open access j...rmally induced during tissue repair while elevated...rosis. In the paper Andrew Leask and his colleague...
... may hitch a ride on the wind, but a new study in ...l Press publication, confirms that they are anythi...rent Biology offered the first evidence that Silv...s, sailing on favorable winds to reach their south...ow, the research team that brought us that finding...
Other Biology News:Biologists, educators recognize excellence in evolution education 2Biologists, educators recognize excellence in evolution education 3Closing the gap: Journal launch brings together wound-healing knowledge 2Migratory moths may hitch their rides, but they're anything but drifters 2
...dominantly used for labeling proteins, the single ...ptides and nucleotides because they give better re...ed in the conjugation processes. 5-TAMRA is more o...roteins. 6-TAMRA is predominately used for labelin...
Chicken Anti-Lactate Dehydrogenase Antibody, Unconjugated from Immunology Consultants Laboratory, Inc.
Mouse Anti-LAP2 Monoclonal Antibody, Unconjugated, Clone 6E10 from Abcam
5% Alkali-Soluble Casein from Novagen
Biology Products: